Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype.
Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype.
复制标题
DOI：
10.1038/srep46791
复制
发表时间：
2017-05-02
影响因子：
4.6
通讯作者：
Yang X
中科院分区：
文献类型：
--
作者：
He Q;Jing H;Liaw L;Gower L;Vary C;Hua S;Yang X
我们感谢罗伯特·弗里塞尔博士对手稿的批判性阅读。我们感谢MMCRI组织学核心Armie Mangoba、Katrina Abramo和Volkhard Lindner博士创建了乳腺癌组织阵列(TMA)和组织化学分析。我们感谢MMC生物库Robert Ackroyd、艾维特·F·埃默里博士和安妮·布雷吉亚博士协调对临床标本的研究。这项研究得到了缅因州癌症基金会加速拨款和缅因州医学中心研究计划拨款给XY的支持这项工作得到了缅因州癌症基金会的拨款和NIH授予D.Wojchowski，PI和P30 GM103392(组织病理学和细胞成像核心)的P30 GM1033465(分子表型、组织病理学和祖细胞分析核心)的赠款和缅因州医疗中心的慷慨支持。
“We thank Dr. Robert Friesel for critical reading of the manuscript. We thank MMCRI histology core Armie Mangoba, Katrina Abramo and Dr. Volkhard Lindner for creating breast cancer tissue array (TMA) and histochemistry analysis. We thank MMC BioBank Robert Ackroyd, Dr. Ivette F. Emery and Dr. Anne Breggia for coordinating studies on clinical specimens. This study was supported by the Maine Cancer Foundation Accelerate Grant and a Maine Medical Center Research Program Grant to XY This work was supported by a grant from the Maine Cancer Foundation and NIH grants P30 GM1033465 (molecular phenotyping, histopathology, and progenitor cell analysis cores) to D. Wojchowski, PI, and P30 GM103392 (Histopathology and cell imaging cores) to R. Friesel, PI, and generous support from the Maine Medical Center”.